Quick Answer
Vicarious Surgical Inc. reported Cash And Cash Equivalents At Carrying Value of $2.57 million for the year ending 2025.
- Vicarious Surgical Inc. showed a decrease of -73.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Vicarious Surgical Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2019: $2.30 million | Q3 2020: $20.43 million | Q1 2021: $1.03 million | Q2 2021: $7.71 million | Q3 2021: $185.05 million | Q2 2022: $141.32 million | Q3 2022: $126.80 million | Q1 2023: $54.08 million | Q2 2023: $32.81 million | Q3 2023: $59.11 million | Q1 2024: $38.22 million | Q2 2024: $20.25 million | Q3 2024: $7.07 million | Q1 2025: $2.60 million | Q2 2025: $3.91 million | Q3 2025: $3.16 million.
- Over the full 6 years of available data (2020 to 2025), Vicarious Surgical Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 84.8%.
- Historical annual values: Fiscal year 2025: $2.57 million | Fiscal year 2024: $9.74 million | Fiscal year 2023: $52.82 million | Fiscal year 2022: $116.21 million | Fiscal year 2021: $173.51 million | Fiscal year 2020: $16.87 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: